ArcticZymes Technologies
1 investor følger denne virksomhed
ArcticZymes Technologies is a biotechnology company. The company specializes in the research and development of pharmaceuticals for the treatment of immune diseases. The main focus is on the development of glucans, the development of immune-stimulating agents, and the analysis of enzymes. The vision is to test and develop the medicine and then pass these on in use for RNA and DNA processes. ArcticZymes Technologies previously went by the name Biotec Pharmacon and is headquartered in Tromsö.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
AZT
Daglig lav / høj pris
-
Markedsværdi
-
Aktieomsætning
-
Volumen
-
Finanskalender
Delårsrapport
22.08.2024
Delårsrapport
06.11.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Skandinaviska Enskilda Banken AB | 12,8 % | 12,8 % |
Skandinaviska Enskilda Banken AB 2 | 7,3 % | 7,3 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
ArcticZymes Technologies ASA: Registration of share capital following exercise of options
ArcticZymes Technologies ASA: Increase of share capital related to exercise of options
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools